LabLynx ELab LIMS Overview: Features, Pricing & Who It’s For (2026)
LabLynx is one of the longest-running LIMS companies in the United States, with a history that stretches back to 1992 and a product claim that is independently verifiable: it was among the first companies to demonstrate a browser-based LIMS, doing so at Pittcon in 1997 — at a time when most LIMS products still required client-side installation. That heritage is real and relevant. LabLynx has been building, hosting, and supporting web-based laboratory information management systems for nearly three decades. The company is privately owned, bootstrapped, and small. CEO and founder John H. Jones incorporated LabLynx, Inc. in July 2000 after separating it from its parent company Atlanta Systems Consultants, Inc. As of April 2026, LabLynx has approximately 14 employees (RocketReach) and is headquartered in the Atlanta, Georgia area. Crunchbase describes it as bootstrapped. Tracxn lists it as unfunded. This is not a venture-backed scale-up; it is an owner-operated specialist software company that has served laboratory clients continuously for over 25 years. Buying context matters here. LabLynx sits in a different market segment from the enterprise LIMS vendors in this series (STARLIMS, LabWare, Sapio Sciences) and from the well-funded mid-market cloud platforms (QBench, Scispot, Benchling). It is a small, bootstrapped, specialist provider with a long track record and a configurable platform. Labs that fit its target profile can get a capable, compliant, cloud-hosted LIMS at lower cost and with faster deployment than enterprise alternatives. Labs that need the deepest feature sets, the largest support organisation, or a vendor with hundreds of named case studies published externally will need to weigh those factors. This article draws on lablynx.com, Wikipedia, LIMSWiki, the LabLynxPress wiki, Tracxn, Crunchbase, Datanyze, RocketReach, Bloomberg Businessweek, John Jones’ LinkedIn profile, G2 (2 reviews, 4.8/5 — verified April 2026), Capterra, Sourceforge, IntuitionLabs LIMS guide (2025), and competitor analyses from Scispot (November 2025, January 2026). LabLynx has not reviewed, sponsored, or paid for this article. Company history — from ASC to LabLynx LabLynx’s origins predate the company itself. In 1992, Atlanta Systems Consultants, Inc. (ASC) was formed as a diversified IT consulting firm. Within ASC, a division began developing a LIMS product specifically designed to run in a web browser — an unusual approach for the mid-1990s, when LIMS software was almost universally delivered as thick client software requiring installation on each workstation. Date Milestone Detail 1992 ASC formed Atlanta Systems Consultants, Inc. (ASC) incorporated in Georgia. Begins development of a browser-based LIMS product under the LabLynx division name. 1997 Pittcon debut ASC demonstrates its Internet Explorer-based LabLynx LIMS at Pittcon — among the first browser-based LIMS products shown publicly (Wikipedia, LIMSWiki). Returns to Pittcon in 1998. Late 1990s US Customs contract LabLynx wins a major LIMS-based contract with the U.S. Customs Service shortly after its Pittcon appearances (Wikipedia). Jul 2000 LabLynx, Inc. incorporated LabLynx division separates from ASC to become its own incorporated entity. CEO and founder: John H. Jones (Tracxn, LinkedIn). Incorporated per Georgia Secretary of State (LIMSWiki). ASC ceases to exist in 2005. 2001 ASP model / ELab The browser-based product becomes ELab, distributed under an application service provider (ASP) model — a precursor to modern SaaS (Wikipedia, LIMSWiki). 2004 openLIMS released LabLynx releases openLIMS, a browser-based tool allowing consultants and end-users to build custom LIMS solutions without vendor involvement (Wikipedia). 2006 Laboratory Informatics Institute LabLynx founds the Laboratory Informatics Institute on 19 June 2006 — an open trade association for the lab informatics industry. Also publishes LIMSfinder (industry magazine) and LIMSbook (buyer’s guide) (Wikipedia). 2011 Health IT initiative LabLynx participates in a U.S. ONC-backed laboratory results interface (LRI) pilot to standardise transmission of lab data to electronic health records (Wikipedia). 2015 HealthCloudPOL Releases HealthCloudPOL, a cloud-based LIS for physician office laboratories (Wikipedia). 2019 CannaQA LIMS Releases CannaQA LIMS specifically for cannabis testing labs. Renamed “ELab LIMS for Cannabis Testing” by 2022 (Wikipedia). 2020 CovidLIMS In April 2020, LabLynx adapts ELab LIMS to manage COVID-19 testing workflows — described as the first dedicated COVID-19 LIMS (PRNewswire, 9 April 2020). 2026 Current status lablynx.com active. ELab LIMS is the flagship product. Platform rebranded as the LabLynx Next Generation Informatics Platform, combining LIMS Suite, ELN Suite, and Lab Automation Suite. ~14 employees. HQ: Atlanta/Smyrna, Georgia. Company scale context With approximately 14 employees, LabLynx is the smallest company reviewed in this series. For buyers, this means: a highly personalised sales and support relationship; faster response times for custom configurations (a consistent theme in independent analyses); and a product roadmap that is not driven by institutional investors. It also means a smaller support organisation, a narrower published case study library, and a G2 review base (2 verified reviews as of April 2026) that is too small to draw statistically meaningful conclusions. Buyers should conduct thorough reference checks with existing LabLynx customers in their industry and deployment size. At a glance Field Details Legal name LabLynx, Inc. Incorporated July 2000, Georgia, USA (Georgia Secretary of State, per LIMSWiki) CEO and founder John H. Jones (LinkedIn, Tracxn). Founder of LabLynx, Inc. and the Laboratory Informatics Institute. HQ Atlanta/Smyrna, Georgia, USA. Address listed by Datanyze: 2400 Lake Park Dr SE, Ste 435, Smyrna, Georgia 30080. Employees ~14 (RocketReach). Crunchbase confirms bootstrapped (no external funding). Ownership Privately owned and funded. Bootstrapped per Crunchbase. No external investors listed on Tracxn or Crunchbase. CEO John Jones is founder and owner. Flagship product ELab LIMS (also marketed as the LabLynx LIMS Suite). Browser-based, cloud-hosted or self-hosted. Platform suite LIMS Suite + ELN Suite + Lab Automation Suite = LabLynx Next Generation Informatics Platform. Modular: LIMS, LIS, LES, ELN, SDMS, Lab Portal, Reporting & Analytics, AI/IoT Automation, Document & Quality Management, and industry-specific modules. Deployment Cloud-hosted (SaaS, LabLynx-managed) or self-hosted (client-managed). Both confirmed on LIMSWiki and lablynx.com. Browser-based: no client installation required on workstations. Industries served Clinical/healthcare, environmental, forensics and medical examiner, agriculture, food & beverage, manufacturing, cannabis testing, pharmaceutical/biotech, construction & engineering. Confirmed across lablynx.com industry pages and Wikipedia. Notable history Contract with U.S. Customs Service (late 1990s, Wikipedia). First dedicated COVID-19 LIMS (April 2020, PRNewswire). Founded the
CloudLIMS Review: Features, Pricing & Who It’s For (2026)
CloudLIMS is a web-based, cloud-only Laboratory Information Management System (LIMS) founded in 2013 and headquartered in Wilmington, Delaware. According to its own About Us page, the company is an ISO 9001:2015 certified informatics company, and PR.com and LinkedIn both confirm its founding year and location. It is a privately held, bootstrapped company — Tracxn and Crunchbase both confirm no external funding has been raised. CloudLIMS operates with a team of 11–50 employees (LinkedIn, ZoomInfo) and serves customers in over 100 countries — a figure stated on the company’s homepage and corroborated in third-party review write-ups. The platform is structured around the premise of zero upfront cost: all listed prices are subscription-only, and complementary services including technical support, instrument integration, legacy data migration, workflow configuration, one CoA template, product upgrades, and automatic backups are bundled into the subscription rather than billed separately. CloudLIMS occupies a well-defined position in the mid-market: it targets testing labs, biobanks, and clinical labs that need a fully web-based, compliance-ready LIMS with volume-scaled pricing — without the enterprise implementation burden of platforms like LabWare or LabVantage. Its most direct market comparison is QBench, with meaningful differences in pricing model, feature bundling, and industry verticals served. This article is based exclusively on CloudLIMS’s official website and pricing page (fetched directly in April 2026), G2, Capterra, GetApp, Software Advice, Sourceforge, LinkedIn, ZoomInfo, Datanyze, PitchBook, Tracxn, and published press releases on cloudlims.com, PR.com, and Biobanking.com. CloudLIMS has not reviewed, sponsored, or paid for this article. At a glance Field Details Vendor CloudLIMS.com LLC Founded 2013 Headquarters Wilmington, Delaware, USA (4023 Kennett Pike #50373). Development team in India (ZoomInfo, LeadIQ). CEO Arun Apte (named in SOC 2 Type 1 press release, February 2022, cloudlims.com) Ownership Privately held, bootstrapped. No external funding raised (Tracxn, Crunchbase). Employees 11–50 (LinkedIn). ~29–40 across data sources (LeadIQ: 29 as of July 2024; PitchBook: 40; ZoomInfo: 11–50). Certifications ISO 9001:2015 certified (confirmed on About Us page and multiple press releases). SOC 2 Type 2 compliant (announced cloudlims.com, 2023; confirmed PR.com September 2025). Deployment Cloud-only SaaS. Fully browser-based. No installation required. No on-premise option. Platform scope LIMS core + QMS support + Client Portal + Billing/Invoicing + Instrument Integration + Document Management + Staff Training Module + CAPA Module + Inventory Management ELN included No. CloudLIMS is a LIMS-first platform. No ELN component. Key industries Biobanking/biorepository, clinical diagnostics, clinical research, analytical testing, cannabis, environmental, food & beverage, veterinary, oil & gas, materials testing, water, mining, genomics, psychedelics Global reach Customers in 100+ countries (cloudlims.com homepage). Attends ISBER annually, including ISBER 2025 Argentina Regional Meeting (September 2025). Named customers University of Sheffield Biorepository (jointly presented ISBER 2017 poster). Fidelis Research (biospecimen collection sites in Bulgaria, Romania, Croatia, Serbia, Turkey; named on cloudlims.com homepage). LTL (Rhode Island cannabis lab; G2/Capterra review by director Cesar Marquez). Free tier FreeLIMS — a separate free product with basic features. No credit card required. Available at freelims.com. Limitations noted by G2 reviewers include restricted database access and absence of API. Pricing Publicly listed, volume-scaled per-user model. Starts at $285/user/month for 5 users (3rd party labs, billed annually). Full pricing table below. G2 profile Listed on G2. G2-generated review summary identifies Customer Support (8 mentions), Functionality (6), Ease of Use (6), and Customization (5) as top positive themes. Customization Difficulty (4) and Steep Learning Curve (3) are top negatives. Most recent verified reviews: August 2025. What CloudLIMS does CloudLIMS is a sample-centric LIMS built for labs that run structured, repeatable testing workflows. It is not an ELN or a research notebook. Its architecture is organised around tracking the full lifecycle of samples — from accessioning through storage, testing, reporting, and disposal — with supporting modules for compliance, billing, and quality management. All features documented below are confirmed on cloudlims.com, the G2 listing, or GetApp: Pricing — publicly listed, volume-scaled CloudLIMS publishes its full pricing on cloudlims.com/lims-software-pricing. All figures below were fetched directly from that page in April 2026 and are billed annually. Unlike most LIMS vendors in this series, CloudLIMS publishes complete pricing publicly — making it one of only two vendors in this series (alongside QBench) where buyers can budget accurately before entering a sales conversation. CloudLIMS pricing is split into three segments based on lab type, each with volume-based per-user rates: 3rd party analytical testing labs, veterinary labs, commercial & 3rd party biobanks (min. 5 users) User band Price/user/month (annual) Lab type 5 users $285/user/month 3rd party analytical testing, veterinary, commercial biobank 10 users $200/user/month 3rd party analytical testing, veterinary, commercial biobank 25 users $100/user/month 3rd party analytical testing, veterinary, commercial biobank 50 users $66/user/month 3rd party analytical testing, veterinary, commercial biobank 100 users $42/user/month 3rd party analytical testing, veterinary, commercial biobank In-house analytical testing labs & in-house biobanks (min. 3 users) User band Price/user/month (annual) Lab type 3 users $310/user/month In-house analytical testing, in-house biobank 5 users $285/user/month In-house analytical testing, in-house biobank 10 users $200/user/month In-house analytical testing, in-house biobank 25 users $100/user/month In-house analytical testing, in-house biobank 50 users $66/user/month In-house analytical testing, in-house biobank 100 users $42/user/month In-house analytical testing, in-house biobank Cannabis & clinical diagnostics (3rd party) (min. 4 users) User band Price/user/month (annual) Lab type 4 users $270/user/month Cannabis testing, clinical diagnostics (3rd party) 5 users $285/user/month Cannabis testing, clinical diagnostics (3rd party) 10 users $200/user/month Cannabis testing, clinical diagnostics (3rd party) 25 users $100/user/month Cannabis testing, clinical diagnostics (3rd party) 50 users $66/user/month Cannabis testing, clinical diagnostics (3rd party) What’s included in all paid plans Per cloudlims.com and confirmed by Capterra, every paid subscription includes at no additional charge: unlimited technical support, instrument integration, workflow configuration, one CoA/report template, automatic product upgrades, legacy data migration, and automatic data backups (twice daily per ISBER 2025 press release). There are no separate implementation fees listed — a meaningful structural advantage over competitors such as QBench, which charges $5–10K for training separately. Standard vs Enterprise editions CloudLIMS offers two feature tiers within the subscription. Standard includes sample management, storage, data import/export, barcode scanning, audit trail, HIPAA compliance, validated
Genemod LIMS & ELN Overview: Features, Pricing & Who It’s For (2026)
Who Genemod competes with Genemod is not competing with STARLIMS, BIOVIA, or Waters NuGenesis. It competes with Benchling, Labguru, and Scispot — cloud-native, modern LIMS/ELN platforms aimed at life science R&D labs transitioning away from paper notebooks and Excel. If your lab is a small-to-mid biotech, an academic research group, or an early-stage biopharma team that needs an affordable, easy-to-deploy unified LIMS and ELN, Genemod is in the right comparison set. If your lab is a regulated QC or manufacturing environment requiring a fully validated enterprise LIMS, the enterprise products in this series are more appropriate. Genemod is a Seattle-area software company that builds a unified LIMS and ELN platform for life science research labs. Founded in 2017 or 2018 (Tracxn and PitchBook report slightly different dates) by Jacob Lee (CEO) and Jin Choe (CTO), the company has raised $7.22 million across three funding rounds, with a $4.5 million Seed round closing in May 2023 led by Defy and LDV Partners (Tracxn). Other investors include Canaan, Cercano Management, Dolby Family Ventures, and Looking Glass Capital (PitchBook, 8 investors total). The company participated in SLAS 2024, one of the primary lab automation and screening conferences in the industry. Genemod’s core pitch is consolidation: replace the fragmented mix of Excel spreadsheets, Google Docs, physical freezer logs, and paper notebooks that most small and mid-size labs still operate on, and do it in a single cloud-native platform at a price point below the enterprise LIMS market. The platform manages 10 million+ records (genemod.net homepage). Its most praised feature — confirmed across every independent review source — is the visual freezer management system, which replicates the physical layout of a lab’s freezers on-screen. This article draws on genemod.net (all product, pricing, solutions, and FAQ pages), Tracxn, PitchBook, Crunchbase, G2, Capterra, Sourceforge, the Labsistant competitor pricing page (March 2026 verification, attributed as competitor-authored), and the Genemod pricing FAQ. Genemod has not reviewed, sponsored, or paid for this article. Company and funding context Understanding Genemod’s stage and scale is the most important context for a lab manager making a purchasing decision. This is a seed-stage startup, not a mature software company with decades of development behind it. Tracxn lists approximately 2 employees as of December 2024 (this appears to undercount; PitchBook lists 13 total employees, which is more consistent with an active multi-product software company). The company has raised $7.22M in total funding — meaningful for a seed stage, but modest relative to Benchling ($900M+) or even Scispot ($2.8M ARR on smaller funding). For lab managers, the practical implications of Genemod’s stage are: Vendor risk context for lab managers Genemod requires annual contract commitments (confirmed on FAQ). Before signing, ask specifically: what happens to your data if Genemod ceases operations or pivots; what data export formats are available and how complete they are; and what the transition plan would be to another system. These questions are standard due diligence for any startup LIMS vendor and are not a criticism of Genemod specifically — but they are more important here than for enterprise vendors. At a glance Field Details Founded 2017 or 2018 (Tracxn and PitchBook report different dates). Co-founders: Jacob Lee (CEO) and Jin Choe (CTO). HQ Seattle / Edmonds, Washington, USA (PitchBook: Edmonds, WA; SoftwareSuggest: Seattle). Employees ~13 (PitchBook). Tracxn lists 2, which appears to undercount. Funding $7.22M total over 3 rounds. Latest: $4.5M Seed, May 4, 2023, led by Defy and LDV Partners (Tracxn). Other investors: Canaan, Cercano Management, Dolby Family Ventures, Looking Glass Capital (PitchBook: 8 investors total). Platform Unified LIMS + ELN cloud-native SaaS. Single platform covering inventory (virtual freezers), consumables, order management, equipment scheduling, ELN, protocols, and audit trails. Scale 10M+ records managed (genemod.net homepage). Architecture Cloud-native SaaS hosted on AWS. Annual contracts required. No on-premise option confirmed. Compliance 21 CFR Part 11 compliance supported (FAQ). AWS infrastructure carries ISO 27001, SOC 1, SOC 2 — these are AWS’s own certifications for the infrastructure; Genemod’s own product-level SOC 2 certification is not separately confirmed in public sources. Audit trails and version control built in. AI features AI Agent LIMS (genemod.net/products/ai-lims): AI-powered workflow support, automated spreadsheet column matching, AI-driven recommendations. Described as “in-platform workflow support for every task.” API Open API framework confirmed (research.com, genemod.net FAQ). Languages English (Sourceforge). Pricing Starts at approximately $199/month (Sourceforge; Labsistant competitor page, March 2026 verification). 4 tiers, annual contracts required. 14-day free trial available. Academia plan for .edu emails (discounted, up to 10 users). No permanent free tier. Multi-year discounts available. Industries Biopharma R&D, industrial biotech, biorepository, clinical research, biomanufacturing, contract services, chemistry, diagnostics (genemod.net solutions pages). G2 profile Active, claimed by Genemod. Limited features plan. Verified reviews published. Top G2 praise themes: inventory management, ease of use, user interface, lab management, lab automation. Capterra Listed with non-incentivized verified reviews. Consistent praise for visual freezer management and responsive support. Notable events Participated in SLAS 2024 (Society for Laboratory Automation and Screening). (genemod.net/events/slas2024) What Genemod does — platform by module Genemod’s platform is organised around six functional areas, all available within a single cloud environment. The strength of each area is not uniform: inventory management is mature and heavily validated by user reviews; the ELN is newer and improving; the AI layer is early-stage. 1. Virtual freezer management and inventory (the core differentiator) This is Genemod’s most differentiated and most consistently praised feature. The virtual freezer replicates the physical layout of a lab’s actual freezers — rack by rack, shelf by shelf, box by box — in a visual on-screen interface. Scientists drag samples into their correct positions digitally, and the system maintains a real-world mirror of what is stored where. A Capterra reviewer who came from -80°C freezer management describes it as: “This software is useful for users who prefer better visualizations of real-life environment. Very easy to manage sample data.” Beyond freezers, the inventory module covers: reagent management with customisable item types (presets for common reagent categories, fully custom types for unusual materials); consumable management organised by category and location; advanced search with filters,
SciCord Overview: Features, Pricing & Who It’s For (2026)
SciCord is a cloud-based LIMS and ELN platform built specifically for pharmaceutical and biopharma laboratories. It is narrower in scope than most vendors in this series: it does not target environmental labs, clinical diagnostics, food & beverage testing, or academic research. Its design choices — a spreadsheet-paradigm no-code engine, integrated ELN and LIMS in one codebase, GxP compliance from the ground up — are all oriented at one buyer profile: regulated analytical, development, QC, and manufacturing labs in pharma and biopharma that are transitioning from paper-based or spreadsheet-based processes and need FDA 21 CFR Part 11 compliance without a long enterprise implementation. That focus is both SciCord’s greatest strength and its most important constraint. If your lab fits that profile, SciCord offers a rare combination: a unified ELN/LIMS platform deployable in as few as 30 days, at a price point that independent reviewers describe as far below what comparable feature sets cost elsewhere, with verified FDA audit performance documented across multiple named customers. If your lab sits outside pharma/biopharma — or if you need a public-facing API, a large support organisation, or a substantial peer review base — other vendors in this series will be a better fit. This article draws on scicord.com, SciCord’s published case studies (Pearl Therapeutics/AstraZeneca, Aurobindo, Singota Solutions, Formulated Solutions, Tenaz), the SciCord Gartner Market Guide announcement, LinkedIn, ZoomInfo, LeadIQ, RocketReach, G2, GetApp, and Sourceforge. SciCord has not reviewed, sponsored, or paid for this article. At a glance Field Details Legal name SciCord LLC Founded 2014 (ZoomInfo). Bootstrapped; no external funding confirmed (Crunchbase). CEO & Founder David Strauss (confirmed on LinkedIn company description). Co-founders: Paolo Matrascia and others (LeadIQ, RocketReach). HQ Raleigh, North Carolina, USA. Website address: 8601 Six Forks Road, Suite 400, Raleigh, NC 27615. Other sources list Cary, NC (suburb of Raleigh). Employees Approximately 9–11 as of early 2026 (RocketReach: 9; LeadIQ: ~11). Staff across North America and Europe. Ownership Privately owned and bootstrapped. No funding rounds on Crunchbase. Primary market Pharmaceutical and biopharma. Core verticals: R&D, Analytical Drug Development, QA, QC, Manufacturing, Stability. LinkedIn and scicord.com confirm this explicitly. Oil & gas and CDMO customers also documented in case studies. Platform SciCord Informatics Platform. Unified ELN + LIMS + LES + SDMS + eBR (electronic batch record) in one codebase. No separate module purchases required. Architecture Cloud SaaS hosted on Microsoft Azure. Also includes a SciCord Smart Client — a desktop application for instrument connectivity via RS232 or IP, which does not require granting external server access to the customer network. Key differentiator Spreadsheet paradigm: the entire platform is built around an Excel-like interface and engine. This is a no-code configuration approach where templates are built using spreadsheet formulas and layouts, not custom programming. Deployment Cloud-only SaaS (Azure). No on-premise option confirmed. Deployment in as few as 30 days per scicord.com and comparison page. Languages English and Italian (Sourceforge). Employees across North America and Europe confirmed by LeadIQ. Compliance FDA 21 CFR Part 11, GxP (GLP, GMP), ISO 17025, ALCOA+ data integrity principles. Azure cloud: GDPR, ISO 27001, HIPAA, FedRAMP, SOC 1 and SOC 2. Validation IQ/OQ packages and PQ drafting services provided. Validated solution integration confirmed in Pearl Therapeutics case study. Validation documentation available to accelerate customer’s own validation activities. API No API available (GetApp, confirmed April 2026). Integrations via web services (LIMS, SAP, ESM, Metrology), file transfer, and database access. Integrations Microsoft Excel, JMP Statistical Software, Microsoft Power BI, Spotfire, Microsoft Entra ID (confirmed on Sourceforge). Instrument connectivity via RS232/IP through Smart Client. SAP integration via web services. Pricing Not publicly listed. Quote-based. ROI calculator available on scicord.com. Sourceforge reviewer describes cost as significantly lower than alternatives with comparable features. Gartner Named a Representative Vendor in the 2025 Gartner Market Guide for LIMS (16 April 2025) and the 2025 Gartner Market Guide for ELN (5 May 2025). First time named in the LIMS guide (previously ELN only). G2 profile Listed on G2; profile has limited features and no published pricing (G2 page confirmed). Review count is very small. Alternatives page lists SciNote, CrelioHealth, SciSure, Labguru, and STARLIMS as top alternatives. Free trial / demo Demo available. Free trial not confirmed. The spreadsheet paradigm — what it means for lab managers The central architectural decision that defines SciCord — and the one lab managers most need to understand before evaluating it — is the spreadsheet paradigm. Rather than building a traditional LIMS with form-based screens and a separate ELN, SciCord built its entire platform around an Excel-like interface. Templates are created using spreadsheet-style layouts and formulas. Scientists work in an environment that looks and behaves like a structured spreadsheet. Configuration is done by building or modifying templates, not by writing code or by hiring a developer. For lab managers, this choice has concrete practical consequences: Lab manager note The spreadsheet paradigm is SciCord’s core strength, but it is also a design constraint. Labs that need complex workflow routing, multi-step analytical testing with highly structured result hierarchies, or deep clinical diagnostics functionality may find the spreadsheet model limiting at scale. Before committing, run SciCord through your most complex assay workflows in a demo environment to validate that the template engine covers your specific data structures. Platform capabilities SciCord’s platform integrates five functions in a single codebase, confirmed on scicord.com/scicord-analytical-lab/: ELN (Electronic Lab Notebook) The ELN layer handles experiment documentation, protocol management, and review/approval workflows. The spreadsheet-style entry supports both structured data capture and free-form documentation. Review and approval cycles are built in, with a minimum 30% increase in reviewer turnaround efficiency cited consistently across the platform and case studies. Electronic signatures are 21 CFR Part 11 compliant. Data entry is validated in real time — out-of-specification flags, SOP adherence checks, and expired reagent restrictions are built into templates. LIMS (Laboratory Information Management System) Sample management covers registration with barcode identification, receipt date, sampling date, and batch number. Chain-of-custody tracking and audit trails for all actions are maintained. Sample and reagent inventory is tracked. Instrument interfacing (RS232 or IP) is handled via the
Scispot Review: Features, Pricing & Who It’s For (2026)
Scispot is a cloud-based laboratory informatics platform founded in 2020 by Guru Singh and Satya Singh in Kitchener, Ontario, Canada. The company’s founding insight, as described by co-founder Satya Singh in a GeekWire interview (May 2024), was that “80% of biotech data never gets analyzed” due to paper-based processes, unique file formats, and lack of platform integration in labs. Guru Singh’s previous experience included scaling life science startups including Scientist.com, Science Exchange, and LabTwin. Satya Singh was a data platform executive at Expedia. Within weeks of launching in 2020, Scispot was accepted into Y Combinator’s Summer 2021 batch — confirmed on Scispot’s own blog and the Y Combinator company directory. The company has also completed programmes at Creative Destruction Lab (CDL) in Seattle. According to PitchBook, total funding raised is $606,000 from 11 investors including Communitech, Ontario Genomics, the Federal Economic Development Agency for Southern Ontario, Alliance of Angels, and Creative Destruction Lab. PitchBook lists 23 total employees as of its most recent data point. Scispot positions itself not as a traditional LIMS but as a “Lab Operating System” (LabOS) — a no-code, unified platform integrating ELN, LIMS, and SDMS capabilities in a single system, with a strong emphasis on data integration via its proprietary GLUE engine and AI-powered automation via its Scibot assistant. This article draws exclusively on Scispot’s official website and pricing page, Y Combinator’s company directory, PitchBook, Tracxn, Crunchbase, GeekWire, the Indee Labs press release, G2, Software Advice, and GetApp. Scispot has not reviewed, sponsored, or paid for this article. At a glance Field Details Vendor Scispot Inc. (operating as Scispot.io) Founded 2020 Headquarters Kitchener, Ontario, Canada Co-founders Guru Singh (CEO) and Satya Singh (CPO/COO) Accelerators Y Combinator Summer 2021 batch; Creative Destruction Lab (CDL) Seattle Investors Communitech, Ontario Genomics, FEDAS, Alliance of Angels, Creative Destruction Lab, Pack Ventures (total 11 investors per PitchBook) Funding raised $606,000 (PitchBook). Revenue reported at $2.8M ARR in October 2024 (Latka/GetLatka). Employees 23 (PitchBook). 18 reported by GetLatka. YC directory states 16. Deployment Cloud-only SaaS. Hosted on AWS (AWS GovCloud optionally for government labs). Single-tenant deployments available for high-security requirements. Platform scope LabOS: alt-ELN (Labspaces) + alt-LIMS (Labsheets) + alt-SDMS (Lakehouse) + GLUE integration engine + Scibot AI assistant + Labflows workflow automation Key industries Biotech R&D, CROs, molecular diagnostics, clinical labs, biobanking, pathology, government labs, cell and gene therapy Named customers Arrakis Therapeutics (quoted on website). Indee Labs (press release, May 2023). Persist AI (press release, July 2023). CAN Health Network (June 2025). Compliance 21 CFR Part 11, SOC 2, HIPAA, GDPR, GLP, ISO 17025, CLIA, CAP, ISO 15189 — all documented on scispot.com. Compliance confirmed in Indee Labs press release (HIPAA, SOC 2, CFR Part 11). ELN included Yes — Labspaces (alt-ELN) is part of the core platform AI assistant Scibot — NLP-powered search, workflow recommendations, AI analytics dashboards Pricing Quote-based. Tiered: Essential, Growth, Enterprise. GLUE priced separately by connectivity and data throughput. No publicly listed per-user prices. Free trial Not confirmed. Demo available. G2 rating Listed. Reviews present but count is modest. Most recent activity confirmed through 2024-2025 based on Software Advice profile. What Scispot does Scispot describes its platform as a Lab Operating System (LabOS) — a positioning that explicitly distinguishes it from traditional LIMS. Rather than adopting the established LIMS, ELN, and SDMS categories, Scispot uses the prefix “alt-” (alt-LIMS, alt-ELN, alt-SDMS) to signal a different architectural philosophy: a unified, API-first, data-science-ready platform built for biotech teams that want to eliminate the integration overhead of running separate best-of-breed tools. The platform consists of several interconnected components, all documented on scispot.com: A notable architectural choice: Scispot’s pricing page confirms the platform can be used as individual components (alt-LIMS alone, GLUE alone) or as the full LabOS bundle, providing modular entry points for labs that do not need the full suite from day one. Company context: startup scale in an enterprise market Scispot occupies an unusual position in the LIMS market. It competes for deals against platforms backed by private equity (Sapio Sciences, GHO Capital), decades of customer deployments (LabWare since 1987, LabVantage since 1981), and significant venture capital (Benchling, $418M). Scispot’s total disclosed funding is $606,000 — orders of magnitude smaller than its most prominent competitors. This context matters for buyers evaluating the platform’s long-term viability, support capacity, and enterprise readiness. PitchBook lists 23 employees; GetLatka estimated 18 in 2024; the YC directory listed 16. Revenue was reported by GetLatka at $2.8M ARR in October 2024, up from $1.7M in 2023 — indicating real and growing commercial traction, though at a scale consistent with a startup rather than an established mid-market vendor. Scale note Scispot’s team size and funding position are relevant to procurement decisions in regulated environments. Labs should evaluate: Can Scispot support a multi-site implementation? What contractual SLAs are available? What happens to data and contracts if the company’s growth trajectory changes? These are standard enterprise diligence questions that apply more acutely to a startup-scale vendor than to incumbents. Scispot’s G2 reviewers consistently praise the support team’s responsiveness — delivered partly via Slack channels — which is a model that scales differently from a traditional enterprise support organisation. Deployment and compliance Scispot is cloud-only, hosted on AWS. For government labs with higher security requirements, Scispot’s government LIMS page documents support for AWS GovCloud (US) deployment and single-tenant instances. Standard deployments are multi-tenant. Compliance documentation on scispot.com and confirmed in the Indee Labs press release (May 2023) covers: Scispot’s pricing page references a “GxP validation package for regulated deployments” as an add-on to the Growth tier. IQ/OQ/PQ validation templates and documentation are referenced on the pricing page as available within that package. Validation note Scispot’s pricing page documents IQ/OQ/PQ validation templates and “inspection prep with a dedicated team” as part of a GxP validation package. Unlike some enterprise LIMS vendors, Scispot does not appear to offer a fully pre-validated system equivalent to LabVantage Pharma’s 90-day pre-validated deployment. Labs in heavily regulated GMP environments should clarify the scope and status of validation documentation before committing. Pricing
Autoscribe Informatics Matrix Gemini LIMS Overview: Features, Pricing & Who It’s For (2026)
Autoscribe Informatics is a LIMS software company with one of the longest track records in the market. Its flagship product, Matrix Gemini LIMS, traces its roots to 1981 when Autoscribe Ltd was founded in the United Kingdom. A 40th anniversary press release published in 2021 confirms the founding year and describes some customers as having been with the product since the early 1990s. The corporate structure around Autoscribe is more complex than its product history, and understanding it matters for buyers: the product and brand have passed through two acquisitions in quick succession. In November 2023, Xybion Digital Inc. (TSX.V: XYBN), a Princeton, New Jersey-based life sciences SaaS company, acquired Autoscribe Informatics for US$12.094 million closing payment, as announced in SEC-equivalent filings on the TSX Venture Exchange and confirmed by Yahoo Finance. Then, in July 2025, Instem — a UK-headquartered supplier of preclinical R&D platforms founded in 1969 — acquired Xybion Digital from Banerjee Group LLC, per a Business Wire press release dated 31 July 2025. The Instem press release confirms that Autoscribe’s LIMS business continues under the Autoscribe brand within Instem. As of April 2026, autoscribeinformatics.com remains an active website, the Autoscribe Informatics brand is in active use, and the product is marketed as “Autoscribe Informatics, a Xybion company” — though the parent is now Instem. Matrix Gemini LIMS has 140+ customers as of the Xybion acquisition announcement (November 2023). The G2 profile has not been actively managed for over a year, per G2’s own notice, which is a visible signal of the transition period. Autoscribe participated in Pittcon 2025 (Boston, March 2025) and Lab Innovations 2024 (Birmingham, October 2024), confirming active commercial activity. This article is based on Autoscribe Informatics’ official website, press releases, and case studies; TSX Venture Exchange filings; Yahoo Finance and Newsfile Corp acquisition announcements; the Instem Business Wire press release (July 2025); G2; Capterra; Sourceforge; the 40th anniversary press release (2021); the Matrix Gemini v6.0 announcement (2021); and Tracxn. Autoscribe Informatics has not reviewed, sponsored, or paid for this article. Understanding the ownership chain — why it matters for buyers Matrix Gemini LIMS is a 40+ year old product that has changed corporate hands twice since late 2023. Buyers evaluating a multi-year LIMS contract should understand this chain before committing. All dates and figures below are sourced from official press releases and public filings: Date Event Detail 1981 Founded Autoscribe Ltd founded in the United Kingdom. The Matrix LIMS product begins development. Early 1990s First customers Some customers confirmed by a 2021 press release to have been with Matrix LIMS since this period. 2011 US entity Autoscribe Informatics formed as the US-facing entity, headquartered in Berkshire County (Tracxn). UK operations continue. Nov 2023 Acquired by Xybion Xybion Digital Inc. (TSX.V: XYBN) acquires Autoscribe Informatics for US$12.094M closing payment plus deferred consideration. Autoscribe had revenue of US$6.18M and EBITDA of US$0.678M in FY ending March 2023 (TSX filing). Autoscribe operated 140+ customer deployments at acquisition. 2024–2025 A Xybion company Autoscribe markets itself as “Autoscribe Informatics, a Xybion company.” Combined Xybion/Autoscribe customer base reaches 350+ across 35 countries (Xybion Q3 2024 filing). Jul 2025 Acquired by Instem Instem acquires all shares of Xybion Digital from Banerjee Group LLC. Instem press release confirms Autoscribe™ brand continues within Instem. Xybion’s former CEO Dr Banerjee noted a “40X MOIC for Xybion shareholders.” Instem was founded in the UK in 1969 and focuses on preclinical R&D. Apr 2026 Current status autoscribeinformatics.com is active. Product marketed as Autoscribe Informatics (brand now under Instem). G2 profile flagged as unmanaged for over a year. Buyer note Two acquisitions in under two years is relevant context for any lab evaluating a 5–10 year LIMS contract. The product has genuine 40+ year continuity and the Matrix Gemini codebase is unchanged. However, buyers should confirm: (1) which entity will hold and service the software licence post-Instem acquisition; (2) whether support, SLA, and upgrade commitments remain as previously contracted; and (3) the product roadmap under Instem’s ownership. These are standard due diligence questions that are more material here than for vendors with stable long-term ownership. At a glance Field Details Product Matrix Gemini LIMS (flagship) + Matrix Gemini LIMS Express (small lab entry) + Matrix Tracker (asset/sample tracking) + Matrix Gemini Stability (stability studies) Brand Autoscribe Informatics — now an Instem company (as of July 2025) Product origin 1981 (Autoscribe Ltd, UK). Celebrating 40 years in business in 2021 per company press release. Founder John Boother, Chairman and Founder. Confirmed in multiple press releases and Tracxn. Offices United Kingdom (HQ), United States (near Boston), Australia (near Adelaide). Worldwide distributor network. Customers 140+ at time of Xybion acquisition (November 2023 press release). Combined Xybion/Autoscribe base: 350+ in 35 countries (Xybion Q3 2024 filing). Revenue (Autoscribe pre-acquisition) US$6.18M revenue, US$0.678M adjusted EBITDA for the fiscal year ending 31 March 2023 (TSX Venture Exchange filing, November 2023). Deployment On-premise (client-managed server), hosted/cloud (third-party server managed by Autoscribe or partner), or hybrid. Both desktop client (LAN) and web browser interfaces available within the same licence. Confirmed on autoscribeinformatics.com. Licensing Perpetual licence (one-off fee) or subscription (quarterly). Both confirmed on G2 pricing page (last updated October 2024). ELN included Built-in ELN module confirmed on Scientific Computing World listing. LES (Laboratory Execution System) and QMS also built in. Key industries Pharmaceutical, medical devices, food & beverage, water/environmental, veterinary, biobanking, mining/materials, contract laboratories Named customers (from case studies) Pixelle Specialty Solutions (paper manufacturing QA, US — customer since 2011, upgraded to v6.x in 2023). Swiss Precision Diagnostics/SPD (medical devices, Geneva — Clearblue maker). Nationwide Laboratories (UK veterinary pathology, 1,100+ tests). CIA Labs (contract lab, Missouri). Tungsten West (mining, UK). University of Iceland Laboratory of Pharmacology and Toxicology (forensic, 4,000–5,000 cases/year). Boston Scientific (named on medical device industry page). Compliance FDA 21 CFR Part 11, ISO 17025, GxP, GLP, GMP, cGxP. Confirmed on autoscribeinformatics.com, G2 listing, and product pages. Pricing Quote-based. Not publicly listed. G2 pricing page states: “available either on-premise or on-line, and may be licensed for a one-off fee or via subscription.”
SciSure Overwiew: Features, Pricing & Who It’s For (2026)
SciSure is a Scientific Management Platform (SMP) that combines ELN, LIMS, and Environmental Health & Safety (EHS) capabilities in a single system. It was formed in January 2025 through the merger of two established companies: SciShield, a Boston-based EHS software provider for research laboratories, and eLabNext, a Groningen, Netherlands-based ELN and LIMS platform that was previously owned by Eppendorf Inc. The merger was announced on 30 January 2025 via Newsfile Corp./EINPresswire and confirmed by Strattam Capital, the private equity firm backing the combined entity. SciSure’s positioning is deliberately distinct from the other LIMS vendors in this series: it is not trying to be the best standalone LIMS. Its core claim is that modern scientific organisations are harmed by running disconnected tools for research documentation, sample management, and safety compliance, and that unifying these into one system reduces administrative burden, improves compliance readiness, and creates a more coherent experience for scientists. The term “Scientific Management Platform” (SMP) was coined specifically to differentiate this broader scope from a traditional LIMS or ELN. The combined company launched with 800+ customer organisations, 550,000+ users, and 37,000+ lab groups across Europe, North America, Asia, and Australia — all figures from the merger press release. In September 2025 SciSure further expanded by acquiring Labfolder and Labregister from Labforward, adding a Berlin-based ELN and inventory system with a strong German research community presence (Newsfile Corp., 11 September 2025). G2 lists SciSure with 193 reviews at 4.2/5, drawn from the combined eLabNext and SciShield user base. As of September 2025, SciSure describes itself as trusted by over 1,000 customers worldwide. This article draws on SciSure’s official website, the merger press release (Newsfile Corp./EINPresswire, 30 January 2025), the Labfolder acquisition announcement (Newsfile Corp., 11 September 2025), the Philip Meer CEO appointment press release (republished on scisure.com, October 2024), the Strattam Capital newsroom, Crunchbase, G2, Capterra, GetApp, Sourceforge, and FitGap. SciSure has not reviewed, sponsored, or paid for this article. How SciSure was formed — understanding the component parts SciSure is a brand-new company built from two organisations with longer independent histories. Understanding those histories matters for buyers evaluating the platform’s maturity, customer base, and product integration status. Date Event Detail ~2010 eLabNext founded Founded by Erwin Seinen and Wouter de Jong as Bio-ITech B.V. in Groningen, Netherlands. Products: eLabJournal (ELN), eLabInventory (LIMS), eLabProtocols. Legal entity: Bio-ITech B.V. (confirmed on Crunchbase). Pre-2025 Eppendorf ownership eLabNext operated as a brand of Bio-ITech B.V., part of Eppendorf Group. eLabNext LinkedIn describes it as “a brand of Bio-ITech BV, part of Eppendorf Group”. QBench’s competitor blog notes eLabNext as “mainly being based in the United States.” 2023 Strattam invests Strattam Capital (Austin/San Francisco private equity) invests in SciShield. The Strattam merger press release states this enabled SciShield to “accelerate innovation” and “expand product offerings, operations, and sales teams.” Oct 2024 Philip Meer named CEO Philip Meer appointed CEO of SciShield. Press release (republished on scisure.com) describes 25+ years of global enterprise software leadership. Strattam Capital Partner Neil Willis quoted endorsing the appointment. Jan 2025 SciSure merger launch SciShield and eLabNext merge and rebrand as SciSure. Newsfile Corp./EINPresswire press release dated 30 January 2025. Combined: 800+ customer organisations, 550,000+ users, 37,000+ lab groups. Eppendorf Inc. endorsed the merger and remains a partner. Nathan Watson (SciShield founder) becomes Chief Strategy Officer. Erwin Seinen becomes CRO. Wouter de Jong becomes CPO. Sep 2025 Labfolder acquisition SciSure acquires Labfolder (ELN) and Labregister (inventory management) from Labforward. Announced Newsfile Corp., 11 September 2025. Products to operate under SciSure brand. Strengthens German research community presence. Apr 2026 Current status SciSure Inc. HQ: 3 Center Plaza, Suite 501, Boston, MA 02108. Over 1,000 customers worldwide (Labfolder acquisition press release). G2 Spring 2026 reports: badges across EHS software, ELN, LIMS, and lab inventory management categories (per SciSure website). Integration context SciSure is less than 18 months old as a merged entity as of April 2026. The merger of SciShield (EHS) and eLabNext (ELN/LIMS) represents two distinct products and teams combining under one brand. A G2 reviewer in a regulated lab environment specifically notes that the “frequency of changes and updates” adds “significant revalidation burden.” Labs evaluating SciSure should assess: (1) how deeply the EHS and ELN/LIMS modules are technically integrated vs. presented under one login; (2) the product integration roadmap; and (3) how Labfolder and Labregister will be incorporated. These are standard due diligence questions for a recently merged platform. At a glance Field Details Brand SciSure (formerly eLabNext and SciShield) Formed January 2025 (merger of SciShield and eLabNext) Pre-merger heritage eLabNext: founded ~2010, Groningen, Netherlands (ELN/LIMS). SciShield: Boston, MA (EHS software for research labs, 27,000+ labs before merger). HQ 3 Center Plaza, Suite 501, Boston, MA 02108, USA CEO Philip Meer (appointed October 2024 at SciShield, leads combined entity) Key leadership Nathan Watson (SciShield Founder, Chief Strategy Officer). Erwin Seinen (eLabNext co-founder, Chief Revenue Officer). Wouter de Jong (eLabNext co-founder, Chief Product Officer). Ownership Backed by Strattam Capital (PE, Austin/San Francisco). Strattam invested in SciShield in 2023 before the merger. Customers 800+ unique customer organisations at merger launch (January 2025). 1,000+ customers worldwide after Labfolder acquisition (September 2025). 550,000+ users at launch. 37,000+ lab groups at launch. Customer profile Fortune 100 biopharma organisations, over one-third of US R1 (top research) academic institutions, biotech, healthcare, oil & gas, food safety, retail (merger press release). Platform Scientific Management Platform (SMP): ELN + LIMS + EHS + Integrations. Also incorporates Labfolder and Labregister (acquired September 2025). Deployment Cloud (hosted in ISO-certified data centres), Private Cloud (dedicated server, custom controls), On-Premises. Confirmed on scisure.com/hosting. Note: EHS capabilities only available on Private Cloud or On-Premises. Compliance 21 CFR Part 11, GDPR, GxP, SOC 2 Type II, HIPAA, ISO 27001. Confirmed on scisure.com/solutions/startup and scisure.com/hosting. ELN included Yes — core component. Originally eLabJournal. Now branded as SciSure ELN. EHS included Yes — environmental health & safety management. Inherited from SciShield. Only fully available on Private Cloud or On-Premises hosting tiers. Pricing Not publicly listed. Quote-based. Academic, Industry, and Startup pricing tiers referenced. Free trial available
eLabFTW Overview: Features, Pricing & Who It’s For (2026)
Two things to know upfront 1. The software is completely free. eLabFTW is open-source (AGPLv3 licence). There is no per-seat charge, no paywalled feature tier, and no vendor lock-in. Every feature is available at no cost. 2. Running it requires a sysadmin. eLabFTW is server software. You cannot install it on a laptop and start using it the next day. It runs on a Linux server, deployed via Docker, and requires a systems administrator to install, configure, and maintain it. If your institution lacks this capacity, Deltablot — the company that backs the project — offers managed hosting. Both paths are covered in this article. eLabFTW is the most widely deployed open-source electronic laboratory notebook in the world. It was created by Nicolas CARPi, a research engineer at the Institut Curie in Paris, who built it to solve a problem he faced in his own lab: no suitable ELN existed that was free, flexible, and respectful of researchers’ data sovereignty. He released eLabFTW as an open-source project and developed it as a side project for years before its adoption reached a scale that led him to create Deltablot, the company that provides commercial hosting and support, in April 2019 (deltablot.com/about). As of April 2026, eLabFTW has thousands of instances running worldwide — the project stopped maintaining a list of institutions because there are too many (doc.elabftw.net/faq). In France, it is the official recommended ELN of the CNRS (Centre National de la Recherche Scientifique), the largest fundamental science agency in Europe, following a competitive selection and deployment process with Deltablot and partner company Easter Eggs. In Germany, it is described in the official documentation as “ubiquitous” at universities and private companies. Community meetings run bi-monthly with participants from institutions across Europe, Asia, and North America. No other ELN in this series — and none in the commercial market — comes close to eLabFTW’s breadth of institutional adoption in academic research. That breadth has a structural reason: when software is free, institutions that could never justify a per-seat licence budget can deploy it. Thousands of research groups at universities, institutes, startups, and public research organisations that could not afford proprietary ELNs have chosen eLabFTW specifically because the barrier to adoption is a server and a sysadmin, not a budget line. This article draws on elabftw.net, deltablot.com, doc.elabftw.net (official documentation), the GitHub repository (elabftw/elabftw), the Deltablot blog, Nicolas CARPi’s startup.info interview (September 2023), his LinkedIn activity, the eLabFTW community meeting summaries, and G2. eLabFTW and Deltablot have not reviewed, sponsored, or paid for this article. Understanding the open-source model — what it means practically eLabFTW is licensed under the AGPLv3 licence. This means: the source code is publicly available on GitHub; you can download, inspect, modify, and deploy it for free; there are no hidden features unlocked by payment; and any modifications you distribute must also be made open-source. The development roadmap and issue tracker are entirely public on GitHub — there is no private backlog, no behind-closed-doors feature development. For lab managers, this has three practical implications that are fundamentally different from every other vendor in this series: The IT dependency Open-source does not mean easy to set up. The official elabftw.net homepage states plainly: “eLabFTW should be installed on a server. This means it is not a software that you can download and install on your computer. It must be installed, configured and maintained by a Systems Administrator. If you’re not familiar with containerized services (Podman/Docker/K8s) and GNU/Linux server administration, we recommend our managed hosted solution.” For lab managers at institutions with central IT infrastructure or a technical research data manager, this barrier is modest. For lab managers at small groups without IT support, the Deltablot PRO Hosting service is the practical path to adoption. At a glance Field Details Software eLabFTW — free, open-source electronic laboratory notebook (AGPLv3 licence) Backing company Deltablot (Paris, France). Founded April 2019 by Nicolas CARPi. Creator Nicolas CARPi, research engineer (Institut Curie). Creator, lead developer, and CEO of Deltablot. Current version 5.5 (deltablot.com blog, 2026). Active development with frequent releases. Primary scope ELN (Electronic Lab Notebook). Also includes a resource/inventory database. Not a full LIMS. Deployment Self-hosted (Docker on Linux server, managed by sysadmin) or Deltablot PRO Hosting (managed SaaS). Software cost Zero. 100% free. All features included. No paywalled tiers. Hosting/support cost Free for self-hosted. Deltablot PRO Hosting: quote-based (four tiers confirmed, no published prices). PRO Support for self-hosters: quote-based. Adoption Thousands of instances worldwide (doc.elabftw.net/faq). CNRS (France) official recommended ELN. Ubiquitous in German universities (official documentation). Named institution supporters: University of Freiburg, Georg-August-University Göttingen, French National Research Institute for Sustainable Development (GitHub sponsors). Languages 21+ languages (elabftw.net). Active translations contributed by community. Key features Experiment documentation, protocol templates, resource/inventory database, file attachments, tags and search, electronic signing, trusted timestamping (RFC 3161), blockchain timestamping (Bloxberg), API, team collaboration, SAML/LDAP SSO, 2FA, audit trail, FAIR data export. Compliance GMP compliance guidance document available (doc.elabftw.net). Trusted timestamping supports regulatory recordkeeping. 21 CFR Part 11: partial — audit trail, electronic signatures, and timestamping are confirmed; full reauthentication at signing (required by §11.200(a)(1)) was an open feature request as of July 2025 (GitHub issue #5782). Regulated labs should validate their specific requirements before deployment. API Full REST API. Official Python client (elabapi-python). Community clients: Perl, LabView, Matlab, R. API workshop available on GitHub. Data sovereignty Data stays on your server (self-hosted) or in Deltablot-managed infrastructure. No telemetry, no tracking cookies (confirmed by Nicolas CARPi, startup.info interview). GDPR-compliant. SecNumCloud option (EU-certified French cloud) available for maximum sovereignty. ELN Consortium Member. Promotes the open .eln interoperability format (RO-Crate-based). G2 profile Listed with verified reviews. G2 reviews describe eLabFTW as easy to use, feature-rich, and good for experiment collaboration. Review count is limited compared to commercial ELNs. Community Bi-monthly community meetings. RDM (Research Data Manager) Club with monthly meetings. Template sharing hub in development (pre-alpha as of January 2026). Active GitHub with many contributors. What eLabFTW does — and what it does not Understanding eLabFTW’s scope is the most important
Labguru ELN LIMS Overview: Features, Pricing & Who It’s For (2026)
Labguru is a cloud-based ELN and LIMS platform built specifically for life science and pharmaceutical labs. It combines an Electronic Lab Notebook, a Laboratory Information Management System, inventory management, and informatics tools in a single system. Since April 2024 it has been owned by Battery Ventures, and as of July 2025 it operates under the newly created Cenevo brand — a merger of Labguru and Titian Software (the UK-based sample management company). The Labguru product name, website, and support infrastructure remain in active use alongside the Cenevo brand, and the article below treats them accordingly. One framing distinction matters upfront: Labguru is widely described — by independent reviewers and competitor analyses alike — as an ELN-first, LIMS-second platform. The Battery Ventures acquisition press release (Business Wire, April 2024) itself positions Labguru’s core strength as lab data management, ELN, and informatics, with LIMS as one component of that broader suite. Labs evaluating Labguru primarily for QC-heavy analytical testing workflows with complex result calculations or batch management should read the “Who it’s for” section carefully. This article draws on labguru.com, the Battery Ventures acquisition press release (Business Wire, 17 April 2024), the Cenevo rebrand press release (PRNewswire, 30 July 2025), the Alantra sell-side advisory announcement, The Connected Lab blog (Thermo Fisher, 26 June 2024), the Labguru 2024 Year in Review blog, G2 (163 reviews, 4.6/5), Capterra, Sourceforge, QBench’s independent competitor analyses (August 2025, January 2026), and CB Insights. Labguru has not reviewed, sponsored, or paid for this article. Corporate history and ownership — the Cenevo context The founding year of Labguru appears as either 2007 or 2008 across different sources: the Battery Ventures Business Wire press release and Alantra both cite 2007; the Cenevo About Us page and CB Insights both cite 2008. The discrepancy likely reflects the difference between when the founding idea was developed and when the legal entity (BioData Inc.) was formally incorporated. The article notes both. Understanding the ownership chain is important context for any multi-year software commitment: Date Event Detail 2007/2008 Founded Founded by Jonathan Gross (founder and CTO) in response to lab data management frustration. Legal entity: BioData Inc. HQ listed at 1900 West Park Drive, Westborough, Massachusetts (CB Insights); Cambridge, MA also cited (finsmes.com). Pre-2024 Holtzbrinck Digital Owned by Holtzbrinck Digital, the digital investment arm of Holtzbrinck Publishing Group (a German publishing house). Also noted as a previous investor: Digital Science (CB Insights). Holtzbrinck described Labguru’s development as positioning it as a “tier-1 lab-management software company.” Apr 2024 Battery Ventures acquires Battery Ventures (Boston-based global technology investment firm) acquires Labguru (BioData Inc.) from Holtzbrinck Digital. Terms undisclosed. Financial advisor to Holtzbrinck: Alantra. Labguru joins Battery’s existing portfolio company Titian Software. CEO Ariel Yarnitsky and founder/CTO Jonathan Gross confirmed to remain in their roles (Business Wire). Jun 2022 Titian/Battery relationship Titian Software (founded 1999, London, UK — sample management software) received a significant investment from Battery Ventures in June 2022 (Cenevo press release). This predates the Labguru acquisition. Jul 2025 Cenevo rebrand Titian Software and Labguru rebrand together as Cenevo (PRNewswire, 30 July 2025). The combined entity is headquartered in London, UK. Labguru and Mosaic (Titian’s sample management platform) continue as products under the Cenevo brand. New CEO: Keith Hale. Jonathan Gross becomes Chief Product Officer at Cenevo. Over 950 customers combined; 45,000+ scientist users; 200+ staff; offices in UK, US, Israel, and Poland. Apr 2026 Current status labguru.com is active. Product marketed under the Labguru brand within Cenevo. G2 listing: “Labguru ELN LIMS” — 163 reviews, 4.6/5. Thermo Fisher Scientific partnership active (signed June 2024). Cenevo and Labguru — what it means for buyers The Cenevo rebrand (July 2025) brings Labguru and Titian’s Mosaic sample management platform under one corporate roof. The Cenevo press release explicitly commits that “the trusted Labguru and Mosaic solutions are and will continue to be a core part of our identity, both stand-alone or combined.” Labs evaluating Labguru in 2026 are buying into a Battery Ventures-backed, Cenevo-operated platform. If combined Labguru+Mosaic sample management coverage is relevant to your organisation, the Cenevo relationship is worth exploring. If you only need ELN/LIMS, Labguru operates as a standalone product. At a glance Field Details Product Labguru ELN LIMS (cloud-based) Legal entity BioData Inc. / BioData Ltd. (Labguru trademark registered to BioData Ltd. per QBench) Founded 2007 (Business Wire, Alantra) or 2008 (Cenevo About Us, CB Insights) — both cited Founder/CTO Jonathan Gross (founder). As of July 2025: Chief Product Officer at Cenevo. CEO Ariel Yarnitsky (CEO as of Battery acquisition, April 2024). Keith Hale is CEO of the combined Cenevo entity. HQ (Labguru) Westborough, MA, USA (CB Insights). Cambridge, MA also referenced (finsmes.com). Parent company Cenevo (since July 2025). Backed by Battery Ventures. Previously owned by Holtzbrinck Digital. Cenevo HQ London, UK Users 120,000+ scientists (Battery acquisition press release, April 2024). 95,000+ on Capterra. 45,000+ across combined Cenevo (Labguru + Mosaic). Customers 950+ combined Cenevo customers (Cenevo press release). Labguru described as serving “hundreds of thousands of scientists” in Battery press release. Industries Biotech, pharma, agritech, foodtech, chemical manufacturing, academic research, and industrial labs. Confirmed across labguru.com and Battery press release. Platform scope ELN + LIMS + Inventory Management + Equipment Management + Informatics/AI tools + Protocol Management + Automation + API Primary positioning ELN-first. Multiple independent sources characterise Labguru as ELN-first with LIMS as a secondary component. Deployment Cloud-only. Confirmed across all sources. Web-based; accessible from desktops and mobile devices. No on-premise option confirmed. Languages English, French, Hebrew, Russian, Spanish (Sourceforge) Compliance FDA 21 CFR Part 11, GxP (GLP, GMP). ISO 27001 certified (SoftwareAdvice). Confirmed on labguru.com and multiple review platforms. Pricing Not publicly listed. Quote-based. Academic, Industry, and Startup tiers referenced across review platforms. Free trial available (Sourceforge, confirmed multiple sources). G2 rating 4.6/5 from 163 reviews (G2 November 2025 lab category listing). LIMS-specific sub-listing: 73 reviews as of January 2026 (QBench Best LIMS 2026 article). Top G2 positive themes: Customer Support (24), Lab Management (19), Inventory Management (19), Ease of Use (19), Organisation (16). Integrations SAP QM (deepened 2024
STARLIMS Overview: Features, Pricing & Who It’s For (2026)
STARLIMS is one of the oldest names in LIMS with one of the most complex ownership histories in the market. Founded in Israel in 1986 by Itschak Friedman and Dinu Toiba, it held an IPO in 2007 and was acquired by Abbott Laboratories in 2009 for $123 million (Wikipedia). Abbott retired the brand for 12 years before Francisco Partners acquired the business in July 2021 and relaunched STARLIMS as an independent brand. In January 2026, Francisco Partners sold STARLIMS to Turn/River Capital — a software-focused private equity firm — per a Business Wire press release dated 13 January 2026. CEO Trey Cook remains in place. As of April 2026, STARLIMS is a Turn/River Capital portfolio company, headquartered in Hollywood, Florida. It serves more than 1,100 customers across 2,000+ laboratories in 85+ countries (Turn/River press release and LinkedIn), spans life sciences, manufacturing, public health, clinical diagnostics, food & beverage, chemical, oil & gas, and more, and holds the #1 LIMS position on G2 with 158 reviews at 4.5/5 as of the G2 Fall 2025 report. This article is based on STARLIMS’s official website and press releases, Wikipedia, Business Wire announcements (Labstep acquisition 2023, LPH launch 2024, QM Essentials 2025, Turn/River investment 2026), G2, Capterra, PitchBook, and LinkedIn. STARLIMS has not reviewed, sponsored, or paid for this article. At a glance Field Details Vendor STARLIMS Corporation (STARLIMS Technologies) Founded 1986 in Israel by Itschak Friedman and Dinu Toiba (Wikipedia) HQ Hollywood, Florida, USA CEO Trey Cook Employees ~219 (PitchBook). ~201–500 (LinkedIn). ~85+ countries served. Ownership Turn/River Capital (PE, investment announced January 2026). Previously Francisco Partners (acquired from Abbott, July 2021). Key corporate history 1986: Founded (Israel). 2007: IPO. 2009: Acquired by Abbott Labs for $123M. 2021: Sold to Francisco Partners. Aug 2023: Acquired Labstep ELN. Jan 2024: Launched LPH 1.0 (public health LIMS). Oct 2025: Launched QM Essentials (SMB SaaS LIMS). Jan 2026: Sold to Turn/River Capital. Platform scope LIMS + ELN (Labstep) + LES (Laboratory Execution System) + SDMS (Scientific Data Management System) + Advanced Analytics 2.0 Key industries Life sciences, pharmaceuticals, CDMOs, food & beverage, chemical & agrochemical, oil & gas, consumer goods, contract testing, public health, clinical diagnostics Named customers Bayer (14+ years, CropScience regulatory and GxP labs — 2024 Rewind blog). DuPont (R&D lab ecosystem — 2023 Rewind blog). Sasol (manufacturing, 2023). CDC and 12 US state health authorities (by 2005 per Wikipedia). Elypta, Francis Crick Institute (Labstep ELN, starlims.com). Newform Foods (Labstep ELN). Deployment On-premise, cloud-hosted (managed by STARLIMS), and SaaS. Cloud includes AWS hosting, HIPAA and GDPR compliance, 99.9% availability. QM Essentials is a pure SaaS out-of-the-box product. ELN included Yes — Labstep (acquired August 2023). Modern cloud R&D ELN sold separately and as part of integrated platform. Also a legacy in-platform ELN (noted in reviews as less user-friendly). Compliance 21 CFR Part 11, GxP, GMP, GLP, ISO 17025, HIPAA, GDPR. Confirmed on starlims.com and Capterra cloud description. Pricing Not publicly listed. Enterprise: quote-based. QM Essentials (SMB SaaS): quote-based but deployable in 4–6 weeks. Public sector contracts suggest significant implementation costs for complex deployments. G2 rating #1 LIMS on G2. 4.5/5 from 158 reviews (G2 Fall 2025 report per STARLIMS blog). Leader in LIMS, SDMS, and ELN Grid reports. Momentum Grid Leader. Mid-market badges in Implementation, Usability, and Relationship indices. Free trial Not confirmed. What STARLIMS does STARLIMS positions its platform as a unified R&D Quality Manufacturing Informatics Platform — a suite covering the full laboratory value chain from R&D through QC and manufacturing to commercial release. Its core components, all documented on starlims.com and confirmed in Business Wire press releases: All modules connect in what STARLIMS calls the R&D Quality Manufacturing Informatics Platform — positioning one vendor as able to support a company from first experiment through to commercial batch release. The 2024 Rewind blog confirms Bayer CropScience as the flagship use case for this end-to-end vision. Labstep vs legacy ELN STARLIMS now has two ELN products: Labstep (the acquired cloud-native R&D product) and an older in-platform ELN. G2 and Capterra reviews reference the legacy ELN as “not very user-friendly” with a reviewer noting STARLIMS is “missing the boat on ELN implementation.” The Labstep product is the current strategic investment and is well-reviewed independently. Labs evaluating STARLIMS for ELN should clarify which product applies to their deployment and whether Labstep is included or priced separately. Deployment and compliance STARLIMS supports three deployment models, confirmed on Capterra and starlims.com: Compliance standards confirmed on starlims.com and Capterra include: FDA 21 CFR Part 11, GxP (GMP, GLP), ISO 17025, HIPAA, and GDPR. The Capterra cloud offering specifically confirms HIPAA and GDPR as included in the managed cloud tier. Pricing STARLIMS does not publish pricing publicly. Enterprise platform pricing requires a direct quote. Two real-world data points from public sector procurement records, cited by an independent Scispot analysis blog: These figures are from public sector contracts, which typically reflect competitive bid environments and may not be representative of commercial pricing. They do, however, confirm that complex enterprise STARLIMS implementations involve substantial total cost of ownership. QM Essentials (SMB SaaS) is designed to reduce this — no pricing is published for it either, but its 4–6 week deployment timeframe implies materially lower implementation cost than the enterprise product. Pricing note The only independent pricing signal for STARLIMS in the market comes from public sector procurement disclosures. Commercial pricing is entirely quote-based and will depend heavily on user count, modules selected, deployment model, and implementation scope. Labs should request a total cost of ownership estimate — including implementation, training, and annual support — not just a licence fee. Who STARLIMS is designed for Based on named customers, industry pages, and G2 review profile, STARLIMS is strongest for: STARLIMS is less commonly the right fit for: What users say STARLIMS holds G2’s #1 LIMS position with 4.5/5 across 158 reviews (G2 Fall 2025 report). It is also a Leader in G2’s SDMS and ELN categories, and holds the Momentum Grid Leader badge. Mid-market badges were added in Fall 2025 across Implementation,